Sagimet Biosciences Inc.
(SGMT)
undefined
undefined%
At close: undefined
5.07
15.62%
Pre-market Dec 16, 2024, 04:29 AM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Revenue | 2.00M | - | - | - | - |
Cost of Revenue | - | 130.00K | 134.00K | 124.00K | 88.00K |
Gross Profit | 2.00M | -130.00K | -134.00K | -124.00K | -88.00K |
Operating Income | -30.74M | -31.05M | -23.72M | -11.40M | -14.25M |
Interest Income | 2.86M | 553.00K | 26.00K | 30.00K | 128.00K |
Pretax Income | -27.88M | -30.50M | -24.44M | -11.37M | -14.26M |
Net Income | -27.88M | -30.50M | -24.44M | -11.37M | -14.26M |
Selling & General & Admin | 12.96M | 6.14M | 4.38M | 3.22M | 5.86M |
Research & Development | 19.78M | 24.92M | 19.34M | 8.18M | 8.39M |
Other Expenses | - | 3.00K | -749.00K | - | -73.00K |
Operating Expenses | 32.74M | 31.05M | 23.72M | 11.40M | 14.25M |
Interest Expense | - | - | - | - | 64.00K |
Selling & Marketing Expenses | - | - | - | - | - |
Cost & Expenses | 32.74M | 31.05M | 23.72M | 11.40M | 14.25M |
Income Tax | - | -31.61M | -23.75M | -176.30K | -9.00K |
Shares Outstanding (Basic) | 10.46M | 22.17M | 22.17M | 22.17M | 22.17M |
Shares Outstanding (Diluted) | 10.46M | 22.17M | 22.17M | 22.17M | 22.17M |
EPS (Basic) | -2.66 | -1.38 | -1.1 | -0.51 | -0.64 |
EPS (Diluted) | -2.66 | -1.38 | -1.1 | -0.51 | -0.64 |
EBITDA | -30.74M | -30.37M | -24.31M | -11.25M | -14.11M |
Depreciation & Amortization | - | 130.00K | 134.00K | 124.00K | 88.00K |